The company's capital base is under pressure, as evidenced by total equity contracting from $973.7 million in 2025Q4 to $575.7 million in 2026Q1, reflecting significant sensitivity to operational volatility.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 |
|---|
| Total Assets | 1.2B | 1.26B | 1.16B | 1.11B | 1.11B | 1.15B | 1.04B | 741.63M | 439.28M | 359.12M | 108.9M | 113.32M | 106.66M | 166.43M | 196.3M | 177.94M | 185.84M | 169.71M | 168.75M | 147.45M | 104.93M | 15.16M | 12.9M |
| Asset Growth % | 23.38% | 9.26% | 3.78% | 0.07% | -3.19% | 10.51% | 40.23% | 68.83% | 22.32% | 229.77% | -3.9% | 6.24% | -35.91% | -15.22% | 10.32% | -4.25% | 9.51% | 0.56% | 14.45% | 40.53% | 591.91% | 17.58% | - |
| Total Investment Assets | 4M | 3.5M | 43.04M | 5.93M | 0 | 41.31M | 49.62M | 0 | 211.44M | 170.3M | -204K | -204K | -386K | 0 | 0 | 0 | 0 | 44.18M | 112.5M | 80.12M | 158K | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 211.44M | 170.3M | -204K | -204K | -386K | 0 | 0 | 0 | 0 | 22M | 56M | 40M | 0 | 0 | 0 |
| Short-Term Investments | 35.7M | 3.5M | 43.04M | 5.93M | 0 | 41.31M | 49.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.18M | 56.5M | 40.12M | 158K | 0 | 0 |
| Total Current Assets | 336.61M | 334.35M | 354.48M | 382.35M | 401.08M | 407.59M | 330.99M | 208.15M | 156.17M | 155.74M | 76.14M | 77.54M | 66.47M | 124.46M | 156.06M | 139.66M | 148.59M | 164.15M | 162.09M | 138.15M | 95.37M | 10.45M | 9.66M |
| Cash & Equivalents | 75.11M | 73.72M | 39.2M | 115.72M | 144.4M | 81.93M | 43.76M | 23.47M | 13.09M | 40.29M | 61.78M | 62.71M | 51.41M | 107.06M | 140.85M | 123.61M | 128.07M | 131.34M | 94.14M | 81.39M | 90.32M | 9.41M | 8.71M |
| Receivables | 3.3B | 1.13B | 259.27M | 248.66M | 245.38M | 260.57M | 220.95M | 177.44M | 137.79M | 111.14M | 9.21M | 9.65M | 8.2M | 4.59M | 4.47M | 8.18M | 10.81M | 2.29M | 2M | 1.68M | 1.11M | 128K | 32K |
| Other Current Assets | -812.32M | -873.29M | 1.32M | 733K | 223K | 922K | 646K | 260K | 2.87M | 1.56M | 2.21M | 2.79M | 3.44M | 10.13M | 7.91M | 6.79M | 5.35M | 6.01M | 7.58M | 14.08M | 2.26M | 0 | 0 |
| Goodwill & Intangibles | 22.3M | 22.3M | 0 | 23.6M | 0 | 1.92M | 48.8M | 50.3M | 52.48M | 21.64M | 22.68M | 23.72M | 24.87M | 21.59M | 23.01M | 24.62M | 26.36M | -22M | -56M | -40M | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 40.23M | 40.23M | 40.23M | 14.1M | 14.1M | 14.1M | 14.1M | 14.1M | 14.1M | 14.1M | 14.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 22.3M | 0 | 23.6M | 0 | 1.92M | 8.57M | 10.06M | 12.25M | 7.54M | 8.58M | 9.62M | 10.77M | 7.5M | 8.91M | 10.53M | 12.26M | 0 | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 12.24M | 12.96M | 16.52M | 27.63M | 32.02M | 49.48M | 57.17M | 47.14M | 7.68M | 4.71M | 5.61M | 7.36M | 9.64M | 10.28M | 6.18M | 4.63M | 4.53M | 3.77M | 4.57M | 3.79M | 3.94M | 2.76M | 2.56M |
| Other Assets | 852.26M | 892.86M | 784.43M | 679.76M | 679.51M | 690.3M | 603.06M | 435.79M | 11.28M | 6.51M | 4.47M | 4.7M | 5.68M | 5.52M | 8.12M | 5.64M | 3.25M | 863K | 780K | 975K | 453K | 1.95M | 673K |
| Total Liabilities | 231.46M | 288.82M | 567M | 209.26M | 461.66M | 399.77M | 202.46M | 214.47M | 136.13M | 72.45M | 31.3M | 36.9M | 33.19M | 33.41M | 25.43M | 22.27M | 23.65M | 18.26M | 13.78M | 11.56M | 9.19M | 93.35M | 91.29M |
| Total Debt | 133.2M | 134.35M | 96.92M | 103.16M | 106.8M | 41.37M | 46.56M | 39.06M | 5M | 3.39M | 2.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 221K | 0 | 0 |
| Net Debt | 58.08M | 60.63M | 57.72M | -12.56M | -37.6M | -40.56M | 2.8M | 15.6M | -8.09M | -36.9M | -59.77M | -62.71M | -51.41M | -107.06M | -140.85M | -123.61M | -128.07M | -131.34M | -94.14M | -81.39M | -90.09M | -9.41M | -8.71M |
| Long-Term Debt | 126.27M | 112.95M | 68.46M | 67.75M | 66.13M | 0 | 0 | 0 | 5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-Term Debt | 6.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 221K | 0 | 0 |
| Total Current Liabilities | 44.35M | 99.07M | 96.01M | 78.54M | 60.56M | 75.47M | 84.41M | 112.98M | 60.62M | 25.45M | 27.92M | 31.94M | 26.74M | 27.24M | 20.81M | 18.35M | 20.2M | 15.26M | 13.15M | 11.31M | 8.87M | 6.82M | 4.87M |
| Accounts Payable | 5.59M | 28.32M | 23.45M | 7.2M | 6.73M | 13.75M | 36.92M | 24.55M | 5.69M | 3.25M | 5.11M | 3.01M | 5.96M | 4.38M | 6.12M | 2.39M | 3.57M | 3.25M | 2.19M | 1.5M | 1.44M | 1.08M | 822K |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 308K | 2.57M | 876K | 385K | 959K | 392K | 869K | 1.78M | 926K | 314K | 2.79M | 401K | 427K | 436K | 62K | 523K | 3K |
| Other Current Liabilities | 31.83M | 63.4M | 48.22M | 43.93M | 23.58M | 19.79M | 24.2M | 69.06M | 23.16M | 0 | 0 | 0 | 0 | 0 | 8.24M | 7.9M | 2.67M | 2.68M | 2.71M | 1.7M | 1.29M | 1.18M | 759K |
| Deferred Taxes | 168.46M | 1000K | 1000K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 443K | 329K | 410K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 5.14M | 5.52M | 342.93M | 34.64M | 268.42M | 237.69M | 4.37M | 3.05M | 22.61M | 1.92M | 2.93M | 4.63M | 6.04M | 6.17M | 4.63M | 3.92M | 3.45M | 3M | 628K | 252K | 317K | 86.53M | 86.43M |
| Total Equity | 575.73M | 973.65M | 588.43M | 904.08M | 650.96M | 749.52M | 837.56M | 527.16M | 295.06M | 246.37M | 15.82M | 76.42M | 73.48M | 133.02M | 170.87M | 155.67M | 162.2M | 151.45M | 154.98M | 135.89M | 95.74M | -78.18M | -78.4M |
| Equity Growth % | 100.92% | 65.47% | -34.91% | 38.89% | -13.15% | -10.51% | 58.88% | 78.66% | 19.76% | 1457.34% | -79.3% | 4.01% | -44.76% | -22.15% | 9.76% | -4.02% | 7.1% | -2.28% | 14.04% | 41.94% | 222.46% | 0.27% | - |
| Shareholders Equity | 575.73M | 973.65M | 588.43M | 904.08M | 650.96M | 749.52M | 837.56M | 527.16M | 303.15M | 286.66M | 77.6M | 76.42M | 73.48M | 133.02M | 170.87M | 155.67M | 162.2M | 151.45M | 154.98M | 135.89M | 95.74M | -78.18M | -78.4M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.09M | -40.29M | -61.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 12.01M | 30.12M | 15.25M | 7.28M | 73.8M | 193.21M | 316.15M | 271.85M | 204.97M | 204.72M | 4.62M | 9.5M | 14.26M | 30.47M | 28.74M | 21.66M | 14.94M | -2.54M | -17.89M | -32.06M | -63.66M | -80.13M | -79.72M |
| Common Stock | 45K | 44K | 43K | 41K | 40K | 39K | 38K | 35K | 31K | 30K | 29K | 29K | 29K | 28K | 27K | 26K | 26K | 25K | 25K | 25K | 22K | 5K | 5K |
| Accumulated OCI | 58K | -62K | -234K | -82K | -73K | 390K | 350K | 116K | 127K | 202K | 176K | 193K | 179K | 160K | 185K | 180K | 205K | 223K | 390K | 82K | -203K | -37K | -104K |
| Return on Equity (ROE) | 3.99% | 5.13% | 1.35% | -3.63% | -12.67% | -13.15% | 6.66% | 16.27% | 0.09% | 19.39% | 0.66% | -6.35% | -15.7% | 1.13% | 4.34% | 4.23% | 11.15% | 10.02% | 9.74% | 27.28% | 187.97% | - | - |
| Return on Assets (ROA) | 2.91% | 3.31% | 0.89% | -2.54% | -7.84% | -9.54% | 5.1% | 11.33% | 0.06% | 10.87% | 0.27% | -4.33% | -11.87% | 0.95% | 3.78% | 3.7% | 9.83% | 9.07% | 8.96% | 25.04% | 27.48% | -2.95% | -25.79% |
| Equity / Assets | 47.93% | 77.12% | 50.93% | 81.2% | 58.51% | 65.22% | 80.53% | 71.08% | 67.17% | 68.6% | 14.53% | 67.44% | 68.89% | 79.93% | 87.04% | 87.48% | 87.28% | 89.24% | 91.84% | 92.16% | 91.24% | -515.54% | -607.82% |
| Debt / Equity | 0.23x | 0.14x | 0.16x | 0.11x | 0.16x | 0.06x | 0.06x | 0.07x | 0.02x | 0.01x | 0.13x | - | - | - | - | - | - | - | - | - | 0.00x | - | - |
| Book Value per Share | 17.98 | 31.94 | 20.06 | 32.27 | 23.79 | 27.99 | 31.00 | 21.48 | 14.46 | 12.93 | 0.87 | 4.24 | 4.00 | 6.70 | 8.23 | 7.17 | 6.79 | 6.01 | 5.97 | 5.27 | 4.65 | -4.05 | -17.53 |
| Tangible BV per Share | 17.98 | 31.21 | 20.06 | 31.43 | 23.79 | 27.92 | 29.20 | 19.43 | 11.89 | 11.80 | -0.38 | 2.93 | 2.65 | 5.61 | 7.12 | 6.04 | 5.69 | 6.01 | 5.97 | 5.27 | 4.65 | -4.05 | -17.53 |
Medicare Advantage regulatory churn
As reported in recent financial statements, eHealth's total equity has fluctuated significantly, dropping from $973.7 million in 2025Q4 to $575.7 million by 2026Q1, which suggests that the company's capital base remains highly sensitive to the seasonal earnings volatility inherent in its Medicare-focused brokerage business model.
The sharp contraction in equity over a single quarter indicates that the company's internal capital generation is insufficient to offset operational losses and potential adjustments to contract assets. Investors should monitor whether this trend reflects a structural weakening of the balance sheet or merely the expected cyclicality of the Medicare enrollment period.
Based on the company's reported figures, claims and loss reserves remain nominal at $3.3 million as of 2026Q1, which appears to reflect the brokerage-centric nature of the business rather than the substantial underwriting reserves typically maintained by traditional insurance carriers within the broader healthcare services ecosystem.
While the low reserve level is consistent with a brokerage model, it leaves the company with little margin for error should there be unexpected adverse developments in policyholder retention or commission clawbacks. The lack of significant reserve growth suggests that the company is not building a defensive cushion against potential long-tail liabilities.
According to recent SEC filings, total liabilities reached $231.5 million in 2026Q1, and the company's reliance on equity to fund operations appears to be tightening as the ratio of liabilities to equity shifts, warranting further investigation into the sustainability of current capital allocation strategies during periods of negative earnings.
The company's capitalization profile appears strained by the need to fund high customer acquisition costs while managing a volatile revenue stream. The absence of a robust capital buffer may limit management's flexibility to pursue strategic initiatives or navigate potential regulatory shocks without further dilutive financing.
As indicated by historical financial data, the balance sheet is heavily weighted toward intangible contract assets representing future commission streams, which may be subject to significant impairment if actual churn rates exceed the aggressive assumptions used in the company's proprietary Lifetime Value modeling and revenue recognition frameworks.
This reliance on non-cash contract assets creates a disconnect between the reported balance sheet strength and the actual liquidity available to meet short-term obligations. If the underlying Medicare Advantage policies experience higher-than-anticipated attrition, the company may be forced to write down these assets, further impairing the equity position.
Quick answers to the most common questions about buying EHTH stock.
As of 2025, eHealth, Inc. (EHTH) had total assets of $1.26B including $334.4M in current assets.
eHealth, Inc. (EHTH) carries total debt of $134.4M, offset by $77.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
eHealth, Inc. (EHTH) has total shareholders' equity (book value) of $973.7M ($31.94 book value per share). Book value represents the net worth of the company belonging to common stock holders.
eHealth, Inc. (EHTH) reported a current ratio of 3.37x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.